VANCOUVER, British Columbia--(BUSINESS WIRE)--Feb. 10, 2006--MIV Therapeutics, Inc. (OTCBB:MIVT) (FWB:MIV), a leading developer of new generation biocompatible coatings and advanced drug delivery systems for cardiovascular stents and other implantable medical devices, announced today the further expansion of its program to develop and commercialize advanced biomedical products with the hiring of Vlad Budzynski MD, PhD, as Senior Scientist in Drug Research and Application.
